Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Kristensen

Showing results (221-230 of 320) with videos related to

Pageof 32
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamideSharon A Glynn, Brenda J Boersma, Tiffany M Howe, et al.
Carcinogenesis|October 10, 2013
Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumorsAndliena Tahiri, Suvi-Katri Leivonen, Torben Lüders, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2011
Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signalingVessela N Kristensen, Charles J Vaske, Josie Ursini-Siegel, et al.
Nature|August 18, 2016
Tumour hypoxia causes DNA hypermethylation by reducing TET activityBernard Thienpont, Jessica Steinbacher, Hui Zhao, et al.
Breast Cancer Research : BCR|November 30, 2017
Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patientsThomas Helland, Nina Henne, Ersilia Bifulco, et al.
International Journal of Cancer|August 25, 2019
Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancersMarianne E Nome, Leslie R Euceda, Shakila Jabeen, et al.
Molecular Cancer|May 21, 2010
NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutationsYi-Ping Fu, Hege Edvardsen, Alpana Kaushiva, et al.
Plos One|March 3, 2011
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumorsEspen Enerly, Israel Steinfeld, Kristine Kleivi, et al.
American Journal of Human Genetics|September 13, 2024
Germline polygenic risk scores are associated with immune gene expression signature and immune cell infiltration in breast cancerYuxi Liu, Cheng Peng, Ina S Brorson, et al.
BMC Medical Genomics|November 3, 2011
Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low featuresVilde D Haakensen, Ole Christian Lingjaerde, Torben Lüders, et al.
Pageof 32

Showing results (221-230 of 320) with videos related to

Sort By:
Pageof 32
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamideSharon A Glynn, Brenda J Boersma, Tiffany M Howe, et al.
Carcinogenesis|October 10, 2013
Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumorsAndliena Tahiri, Suvi-Katri Leivonen, Torben Lüders, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2011
Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signalingVessela N Kristensen, Charles J Vaske, Josie Ursini-Siegel, et al.
Nature|August 18, 2016
Tumour hypoxia causes DNA hypermethylation by reducing TET activityBernard Thienpont, Jessica Steinbacher, Hui Zhao, et al.
Breast Cancer Research : BCR|November 30, 2017
Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patientsThomas Helland, Nina Henne, Ersilia Bifulco, et al.
International Journal of Cancer|August 25, 2019
Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancersMarianne E Nome, Leslie R Euceda, Shakila Jabeen, et al.
Molecular Cancer|May 21, 2010
NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutationsYi-Ping Fu, Hege Edvardsen, Alpana Kaushiva, et al.
Plos One|March 3, 2011
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumorsEspen Enerly, Israel Steinfeld, Kristine Kleivi, et al.
American Journal of Human Genetics|September 13, 2024
Germline polygenic risk scores are associated with immune gene expression signature and immune cell infiltration in breast cancerYuxi Liu, Cheng Peng, Ina S Brorson, et al.
BMC Medical Genomics|November 3, 2011
Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low featuresVilde D Haakensen, Ole Christian Lingjaerde, Torben Lüders, et al.
Pageof 32